Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial

(2019) F. E. Buisman et al.   BMC CANCER

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)

(2018) Diane Goéré et al.   BMC CANCER

Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases

(2018) Jeffery Chakedis et al.   JOURNAL OF SURGICAL ONCOLOGY

Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis

(2017) Bas Groot Koerkamp et al.   JOURNAL OF CLINICAL ONCOLOGY

Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy

(2016) Nancy E. Kemeny et al.   JOURNAL OF SURGICAL ONCOLOGY

One-Millimeter Cancer-Free Margin Is Curative for Colorectal Liver Metastases

(2013) Zaed Z. R. Hamady et al.   ANNALS OF SURGERY

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

(2013) Bernard Nordlinger et al.   LANCET ONCOLOGY

Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver

(2010) John B. Ammori et al.   SEMINARS IN ONCOLOGY

Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases

(2009) Gianluca Masi et al.   ANNALS OF SURGERY

The role of floxuridine in metastatic liver disease

(2009) D. G. Power et al.   MOLECULAR CANCER THERAPEUTICS